Condition: Cancer Risk · Breast Cancer Risk · Sponsor: University of California, San Francisco
This is a multi-center, single arm trial to evaluate the cancer detection rate of supplemental screening magnetic resonance imaging (MRI) in participants who are high-risk by Mirai-MRI assessment. Mirai is an accurate cancer risk model based on full-resolution mammograms.
This description comes directly from the study's public registry record.
Tiffany Tran · 877-827-3222 · tiffany.tran3@ucsf.edu
Always discuss trial participation with your own doctor first.
| University of California, San Diego | San Diego, California, United States | Not Yet Recruiting |
| University of California, San Francisco | San Francisco, California, United States | Recruiting |
| University of Chicago Comprehensive Cancer Center | Chicago, Illinois, United States | Not Yet Recruiting |
| University of Massachusetts Memorial Medical Center | Worcester, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07121972